Min Luo
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- RNA Interference and Gene Delivery
- Circular RNAs in diseases
- RNA modifications and cancer
Papers in
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 8
-
- RNA Interference and Gene Delivery 10
- Co-authors
- Xiawei WeiTianxia LanYuan HuMinyang FuKun‐Liang GuanYuquan WeiTing LuoKatherine A. Hajjar
- Journals
- Scientific Reports (9 papers)Biochemical and Biophysical Research Communications (5 papers)Frontiers in Oncology (4 papers)Oncology Reports (4 papers)Oncotarget (4 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Min Luo
190 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Cancer Research 663
- Molecular Biology 2.3k
- Immunology 665
- Oncology 706
- Cell Biology 402
Countries citing papers authored by Min Luo
This map shows the geographic impact of Min Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Luo more than expected).
Fields of papers citing papers by Min Luo
This network shows the impact of papers produced by Min Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Luo. The network helps show where Min Luo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Min Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 14 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 39 | |
| 11 | 2022 | 12 | |
| 12 | 2022 | 22 | |
| 13 | 2022 | 20 | |
| 14 | 2020 | 2 | |
| 15 | 2020 | 69 | |
| 16 | 2014 | 118 | |
| 17 | 2013 | 8 | |
| 18 | Long-Term Regulation of Lipolysis by Insulin in Human Adipocytes | 2005 | 1 |
| 19 | Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis. | 2005 | 33 |
| 20 | 2005 | 6 |
About Min Luo
Min Luo is a scholar working on Cancer Research, Molecular Biology, Immunology, Oncology and Endocrinology, Diabetes and Metabolism, having authored 206 papers that have together received 4.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), Cancer Immunotherapy and Biomarkers (11 papers), RNA Interference and Gene Delivery (10 papers), Thyroid Disorders and Treatments (8 papers), MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Virus-based gene therapy research (7 papers). The work is most often cited by research in Cancer Research (663 citations), Molecular Biology (2.3k citations), Immunology (665 citations), Oncology (706 citations) and Cell Biology (402 citations). Min Luo has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xiawei Wei, Tianxia Lan, Yuan Hu, Minyang Fu, Kun‐Liang Guan, Yuquan Wei, Ting Luo, Katherine A. Hajjar, Zhiyao He and Bin Shao. Their work appears in journals such as Scientific Reports, Biochemical and Biophysical Research Communications, Frontiers in Oncology, Oncology Reports and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.